Foluso A. Fakorede, MD, received his medical degree from UMDNJ-Robert Wood Johnson Medical School in Camden, NJ. He completed his internship and residency at New York Presbyterian Weill Cornell Hospital and returned to New Jersey for a fellowship in cardiology, interventional cardiology, and endovascular intervention at Cooper University Hospital in Camden. Today, he is an expert at preventive cardiovascular management, women’s heart health, and catheter-based procedural focus in coronary atherosclerosis disease (CAD) and peripheral atherosclerosis disease. He has advanced technical skills in preventing amputations, and in 2015 he opened Cardiovascular Solutions of Central Mississippi in Cleveland, located in the Mississippi Delta. Dr Fakorede is a national advocate for ending health disparities in underserved communities.
The Amputation Reduction and Compassion Act (H.R. 2631) would ensure that Medicare and Medicaid both cover peripheral artery disease screening for at-risk beneficiaries without the cost-sharing requirements that could make some patients balk at seeking care.
Atherosclerosis and peripheral artery disease are significant long-term complications of diabetes that demand more education and quality care to prevent limb loss. The conclusion of National Diabetes Month offers an opportunity to draw attention to ways to prevent these outcomes and screen for them early.
Published: November 29th 2018 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
